GW Pharmaceuticals Plc (GWP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:GW Pharmaceuticals Plc (GWP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C5077
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the treatment of spasticity due to multiple sclerosis. It sells and distributes the product through strategic collaborations with other pharmaceutical companies. GW Pharmaceuticals is also developing products for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis, infantile spasms, epilepsy syndrome, glioma, schizophrenia, autism among others. The company has subsidiaries in Australia, the US, England and Wales, and Guernsey. GW Pharmaceuticals is headquartered in Cambridgeshire, the UK.

GW Pharmaceuticals Plc (GWP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GW Pharmaceuticals Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GW Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
GW Pharmaceuticals Plc, Medical Equipment, Deal Details 10
Private Equity 10
Mentor Capital Invests USD1 Million in GW Pharma 10
Equity Offering 11
GW Pharma Raises USD317.4 Million in Public Offering of Shares 11
GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 13
GW Pharma Completes Public Offering Of American Depositary Shares For US$101 Million 15
Acquisition 17
GW Pharma May Sell Itself 17
GW Pharmaceuticals Plc – Key Competitors 18
GW Pharmaceuticals Plc – Key Employees 19
GW Pharmaceuticals Plc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 07, 2018: GW Pharmaceuticals reports fiscal third quarter 2018 financial results and operational progress 21
May 08, 2018: GW Pharmaceuticals Announces Fiscal Second Quarter 2018 Financial Results 23
Aug 07, 2017: GW Pharmaceuticals Reports Fiscal Third Quarter 2017 Financial Results 24
May 09, 2017: GW Pharmaceuticals Reports Fiscal Second Quarter 2017 Financial Results and Operational Progress 26
Feb 07, 2017: GW Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Progress 28
Corporate Communications 29
Dec 21, 2017: GW Pharmaceuticals Announces the Appointment of Three New Independent Members to its Board of Directors 29
May 15, 2017: GW Pharmaceuticals Announces Research & Development Management Appointments 30
Mar 07, 2017: GW Pharmaceuticals Announces the Appointment of Scott Giacobello as Chief Financial Officer and Adam George as Managing Director – UK 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
GW Pharmaceuticals Plc, Medical Equipment, Key Facts, 2017 2
GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GW Pharmaceuticals Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GW Pharmaceuticals Plc, Deals By Market, 2012 to YTD 2018 8
GW Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Mentor Capital Invests USD1 Million in GW Pharma 10
GW Pharma Raises USD317.4 Million in Public Offering of Shares 11
GW Pharma Raises USD126 Million in Public Offering of American Depositary Shares 13
GW Pharma Completes Public Offering Of American Depositary Shares For US$101 Million 15
GW Pharma May Sell Itself 17
GW Pharmaceuticals Plc, Key Competitors 18
GW Pharmaceuticals Plc, Key Employees 19
GW Pharmaceuticals Plc, Other Locations 20
GW Pharmaceuticals Plc, Subsidiaries 20

List of Figures
GW Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
GW Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
GW Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
GW Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
GW Pharmaceuticals Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[GW Pharmaceuticals Plc (GWP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lincoln National Corporation:企業の戦略・SWOT・財務分析
    Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report Summary Lincoln National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • DePuy Synthes Inc:企業の製品パイプライン分析2018
    Summary DePuy Synthes Inc (DePuy Synthes), a subsidiary of Johnson & Johnson, is a medical device company that provides products for orthopedic and neurological procedures. DePuy Synthes operates through eight divisions: joint reconstruction, sports medicine, neurological, spine, trauma, cranio-maxi …
  • PT Berau Coal Energy Tbk:企業の戦略・SWOT・財務情報
    PT Berau Coal Energy Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Berau Coal Energy Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Thetis Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Thetis Pharmaceuticals LLC (Thetis Pharma) is a drug manufacturing company that offers novel immuno-resolving therapies. The company develops and manufactures drugs for type two diabetes and chronic conditions. Its pipeline products include TP252, TP6211, TP113, and TP 101. Thetis Pharma’s T …
  • Lion Pty Ltd:企業の戦略・SWOT・財務情報
    Lion Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Lion Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • RPC Group PLC:企業のM&A・事業提携・投資動向
    RPC Group PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RPC Group PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Black Box Corp (BBOX):企業の財務・戦略的SWOT分析
    Black Box Corp (BBOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sony Financial Holdings Inc.:企業の戦略・SWOT・財務分析
    Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sony Financial Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • GN Store Nord AS (GN):企業の財務・戦略的SWOT分析
    GN Store Nord AS (GN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Saudi Chemical Company (2230):企業の財務・戦略的SWOT分析
    Saudi Chemical Company (2230) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Boustead Heavy Industries Corp Bhd:企業の戦略・SWOT・財務分析
    Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report Summary Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • MetGen Oy:製薬・医療:M&Aディール及び事業提携情報
    Summary MetGen Oy (MetGen) is a manufacturer and distributor of enzymatic solutions. The company offers metzyme, an industrial and natural catalysts used for accelerating chemical reactions. Its enzymatic solutions find applications in various processes such as mechanical processes, lignocellulosic …
  • Integracion Energetica Argentina SA:企業の戦略的SWOT分析
    Integracion Energetica Argentina SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Cellectricon AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Cellectricon AB (Cellectricon) is an advanced cell-based discovery service provider. The company offers automated cell-based screening technologies for drug discovery and basic research. It provides Cellaxess, a platform that allows the researchers to address critical bottlenecks in the drug …
  • Airgain, Inc. (AIRG):企業の財務・戦略的SWOT分析
    Airgain, Inc. (AIRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sareum Holdings Plc (SAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Sareum Holdings Plc (Sareum) is a drug discovery and development company that produces targeted small molecule therapeutics for treating cancer and autoimmune diseases. The drug research programs of the company are based on its proprietary drug discovery technology, Sareum Kinase Inhibitor L …
  • Geberit Ag:企業の戦略・SWOT・財務分析
    Geberit Ag - Strategy, SWOT and Corporate Finance Report Summary Geberit Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Akzo Nobel N.V.:企業の戦略・SWOT・財務情報
    Akzo Nobel N.V. - Strategy, SWOT and Corporate Finance Report Summary Akzo Nobel N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Northstar Electronics, Inc.:企業の戦略・SWOT・財務分析
    Northstar Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Northstar Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Outokumpu Oyj:戦略・SWOT・企業財務分析
    Outokumpu Oyj - Strategy, SWOT and Corporate Finance Report Summary Outokumpu Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆